Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 24, 2012

View Archived Issues

Study reveals new therapeutic use for phosphodiesterase 5 inhibitors

Revalesio set to launch new trial of nebulized asthma combination therapy

SK Biopharmaceuticals begin U.S. phase II trial of SKL-11197

HER2 gene imaging analysis system receives FDA clearance

New hepatocyte growth factor receptor inhibitor advances to clinic

Daiichi Sankyo reviews pipeline progress

Japanese researchers design novel agents for neuropathic pain

Bristol-Myers Squibb presents new anticancer agents

Roche offers overview of 2011

Novel cannabinoid receptor agonists disclosed by Astellas Pharma

Corning presents novel compounds for GPR35 receptor-related disorders

Spanish scientists patent new protein kinase inhibitors

First visceral leishmaniasis vaccine enters clinical testing

Novel agents for pain prepared by Nutek Pharma

New system allows creation and screening of macrocyclic N-methylated peptide libraries

PDUFA date set for Impax Pharmaceuticals' IPX-066 NDA

VX-222 combination therapy shows promise in hepatitis C

New therapeutic target identified for hepatitis C

FDA committee votes on aclidinium bromide NDA

Can-Fite BioPharma product obtains FDA orphan drug status

Cedars-Sinai receives grant for Alzheimer's research

ULURU's Altrazeal obtains approval in Australia

Omeros unlocks new class A orphan GPCRs

EMA grants new marketing approval for dry powder inhaler

EMA accepts Genzyme's teriflunomide MAA

Dosing begins in phase I Vasomera trial

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...